Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
6
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 6 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Cefazolin Sodium* Cefazolin Sodium | D | $4.4M | -16% | 20,069 | $218 | $2.07 |
| Cefazolin Sodium-Dextrose Cefazolin Sodium/Dextrose,Iso | D | $267K | +3% | 622 | $429 | $5.98 |
| Cefazolin Sodium (J0690)* Cefazolin Sodium* · J0690 | B | $92K | -3% | 15,372 | $6 | $0.83 |
| Cefazolin Sodium-Dextrose Cefazolin Sodium/Dextrose,Iso · J0689 | B | $36K | +22084% | 6,795 | $5 | $1.22 |
| Cefazolin Sodium (J0687) Cefazolin Sodium · J0687 | B | $6K | n/a | 1,508 | $4 | $1.04 |
| Cefazolin Sodium (J0688) Cefazolin Sodium · J0688 | B | $622 | n/a | 64 | $10 | $1.06 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.